Qingdao Haier Biomedical Co.,Ltd (SHA:688139)

Market Cap	9.52B -6.1%
Revenue (ttm)	2.29B +0.3%
Net Income	219.93M -35.2%
EPS	0.70 -34.7%
Shares Out	311.71M
PE Ratio	43.60
Forward PE	31.97
Dividend	0.33 (1.08%)
Ex-Dividend Date	Jun 6, 2025

Volume	4,271,343
Open	30.64
Previous Close	30.53
Day's Range	29.26 - 30.69
52-Week Range	29.36 - 38.80
Beta	0.56
Analysts	Strong Buy
Price Target	37.00 (+26.02%)
Earnings Date	Aug 21, 2026

About SHA:688139

Qingdao Haier Biomedical Co.,Ltd engages in the research and development, manufacture, marketing, and sale of low temperature storage equipment for biomedical samples in China and internationally. The company offers ULT freezers, pharmacy refrigerators, freezers, automatic storage solutions, cryogenics, active temperature controlled RKN containers, and RTMD products; and CO2 incubation, standard incubators, biological safety cabinets, clean benches and laminar, and sterilization products. It also provides floor standing, benchtop refrigerated, ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 2,945
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688139

Financial Performance

In 2025, SHA:688139's revenue was 2.33 billion, an increase of 1.96% compared to the previous year's 2.28 billion. Earnings were 250.73 million, a decrease of -31.61%.